Skip to Content

Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)

Licence status
Authorised: 20/04/2001
Active substances
Pertactin, Filamentous haemagglutinin, Pertussis toxoid, Tetanus toxoid, Diphtheria toxoid
Dosage Form
Suspension for injection in pre-filled syringe
Licence number
PA1077/020/001
Licence holder
GlaxoSmithKline (Ireland) Limited

Licence information

ATC code
J07AJ52 pertussis, purified antigen, combinations with toxoids
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Batches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC, as amended.
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/04/2001

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie